Use the Back button in your browser to see the other results of your search or to select another record.

Detailed Search Results

Five-animal frolics exercise improves anxiety and depression outcomes in patients with coronary heart disease: a single-blind randomized controlled trial
Jiang J, Chi Q, Wang Y, Jin X, Yu S
Evidence-Based Complementary and Alternative Medicine 2020;(6937158):Epub
clinical trial
6/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: Yes; Intention-to-treat analysis: Yes; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed*

INTRODUCTION: The patients with coronary heart disease (CHD) always have emotional implications. As the branch of traditional Chinese medicine, five-animal frolics exercise (FAE) is a popular mind-body exercise in China and shown to improve emotional wellbeing. AIM: We aimed to explore the effects of FAE on the emotional disorders of CHD patients. METHODS: CHD patients were assigned into an experiment group (EG, FAE) and a control group (CG, routine nursing care). We measured serum levels of miR-124 and miR-135 and scores of the Hamilton Depression/Anxiety scale (HAMD/HAMA), Self-Rating Anxiety Scale (SAS), the Self-Rating Depression Scale (SDS), Short Form 36 Health Survey Questionnaire (SF-36), and Pittsburgh Sleep Quality Index (PSQI). RESULTS: After a 3-month FAE intervention, serum levels of miR-124 and miR-135 and the scores of HAMD/HAMA, SAS, SDS, and PSQI in the EG group were lower than those in the CG group, while SF-36 scores in the EG group were higher than those in the CG group (p < 0.05). Serum levels of miR-124 and miR-135 had a strong relationship with SAS and SDS scores (p < 0.05). DISCUSSION/IMPLICATIONS FOR PRACTICE: The study suggests that FAE intervention controls anxiety and depression outcomes and improves life quality in CHD patients by affecting serum levels of miR-124 and miR-135.

Full text (sometimes free) may be available at these link(s):      help